Search results for Caspase-3 antibody

Anti-Caspase-3 antibody [31A1067], Abcam, AB13585

Anti-Caspase-3 antibody [ABM1C12], Abcam, AB208161

Anti-Caspase-3 antibody [E87], Abcam, AB32351

Anti-Caspase-3 antibody [E87] (ab32351) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P, IP, WB in human samples. Anti-Caspase-3 antibody [E87] (ab32351) has been cited over 386 times in peer reviewed journals and is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-Caspase-3 antibody [E87] (ab32351) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-Caspase-3 antibody [E87] (ab32351) has been confirmed by testing in knockout samples. Anti-Caspase-3 antibody [E87] (ab32351) has 11 independent reviews from customers. Anti-Caspase-3 antibody [E87] (ab32351) specifically detects Caspase-3 (UniProt ID: P42574; Molecular weight: 17kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Conjugation-ready, carrier free format available for antibody clone E87 - ab197202 . Antibody clone E87 is also available pre-conjugated to a variety of labels for your convenience - Biotin, PE, APC, HRP, Alkaline Phosphatase, Alexa Fluor® 488, Alexa Fluor® 647, Alexa Fluor® 594 ( ab195905 , ab305665 , ab305666 , ab305667 , ab308706 , ab309678 , ab310040 , ab310425 ). Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Caspase-3 antibody [EPR18297], Abcam, AB184787

Anti-Caspase-3 antibody [EPR18297] (ab184787) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in IHC-P, IP, WB in human, mouse, rat samples. Anti-Caspase-3 antibody [EPR18297] (ab184787) has been cited over 223 times in peer reviewed journals and is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-Caspase-3 antibody [EPR18297] (ab184787) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-Caspase-3 antibody [EPR18297] (ab184787) has been confirmed by testing in knockout samples. Anti-Caspase-3 antibody [EPR18297] (ab184787) specifically detects Caspase-3 (UniProt ID: P42574; Molecular weight: 17kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Caspase-3 antibody [RM1299], Abcam, AB323369

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are recombinant multiclonals? Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including: - The sensitivity of polyclonal antibodies by recognising multiple epitopes - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production View our range of recombinant multiclonal antibodies .

Anti-Cleaved Caspase-3 antibody, Abcam, AB2302

Product Specifications Anti-Cleaved Caspase-3 antibody (ab2302) is a rabbit polyclonal antibody and is validated for use in WB in human, recombinant fragment samples. Anti-Cleaved Caspase-3 antibody (ab2302) specifically detects Cleaved Caspase-3 (UniProt ID: P42574; Molecular weight: 17kDa) and is sold in 50 µg selling sizes. Quality and Validation Abcam's high quality validation processes ensure Anti-Cleaved Caspase-3 antibody (ab2302) has high sensitivity and specificity. Anti-Cleaved Caspase-3 antibody (ab2302) has been cited over 1368 times in peer reviewed journals and is trusted by the scientific community. Anti-Cleaved Caspase-3 antibody (ab2302) has 55 independent reviews from customers. Target Information Cleaved Caspase-3 is a crucial marker of apoptosis, the programmed cell death process. It is the activated form of Caspase-3, resulting from proteolytic cleavage. Cleaved Caspase-3 plays a vital role in executing apoptosis by cleaving various cellular substrates, leading to cell dismantling. Researchers use Cleaved Caspase-3 as a reliable indicator of apoptosis in studies of cancer, neurodegenerative diseases, and other conditions involving cell death. Its detection is essential for understanding the mechanisms of apoptosis and developing targeted therapies. In cancer research, cleaved Caspase-3 is used to assess the effectiveness of anti-cancer therapies that induce apoptosis in tumor cells. Elevated levels of cleaved Caspase-3 have been associated with better prognosis in certain cancers, such as oral tongue squamous cell carcinoma. Additionally, cleaved Caspase-3 has been implicated in non-apoptotic roles, such as promoting angiogenesis and chemotherapy resistance. Neurodegenerative Diseases: In neurodegenerative diseases like Alzheimer's (AD) and Parkinson's (PD) disease, cleaved Caspase-3 is involved in the apoptotic pathways that lead to neuronal cell death. For instance, caspase-3-cleaved Tau aggregates more easily than full-length Tau, contributing to the pathology of Alzheimer's disease. Understanding the role of cleaved Caspase-3 in these diseases helps researchers develop targeted therapies to mitigate neuronal loss and disease progression. This product is manufactured by BioVision, an Abcam company and was previously called 3015 Anti-Caspase-3 (Active) Polyclonal Antibody. Caspases are synthesized as inactive pro-enzymes that are processed to active form in cells undergoing apoptosis. Caspase 3 has been extensively studied and implicated to play an important role in apoptosis. Active caspase 3 proteolytically cleaves and activates other caspases, as well as relevant targets in the cells (e.g., PARP). This affinity purified antibody recognizing the active forms of caspase-3 provides a new tool for identifying apoptotic cell populations in both tissue sections and cultured cells.

Biotin Anti-Caspase-3 antibody [E87], Abcam, AB195905

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .

HRP Anti-Caspase-3 antibody [E87], Abcam, AB305667

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Caspase-3 Antibody (YA4015)(PBS only), MedChemexpress, HY-P84318A

Caspase-3 Antibody (YA4015) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Caspase-3.

Anti-pro Caspase-3 antibody [E61], Abcam, AB32150

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Species reactivity Rat: We have preliminary internal testing data to indicate this antibody may not react with this species. Please contact us for more information.